[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fP8sQxAHx_fWTTY6v2hjE7grGyM38jdoC3TkRR0iyd94":3},{"answer":4,"createTime":5,"id":6,"options":7,"origin":12,"question":19,"related":20,"source":30,"type":31},[],"2025-11-21 11:15:32",238557800,[8,9,10,11],"基因突变","旁路激活","药物口服吸收差","信号通路代偿",{"count":13,"courseId":14,"courseImg":15,"courseName":16,"workId":17,"workName":18},10,"53e1d2ef4961cca8eea3e23969ad2cb9","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002F03a579384a6dc297c89809b582fcc767.png","默认课程","work_48390018","新建作业20251120222544","靶向治疗中"耐药性"的主要机制不包括",[21,32,41,50,59,68,76,79,88,95],{"answer":22,"createTime":5,"id":23,"options":24,"question":29,"source":30,"type":31},[],238557794,[25,26,27,28],"靶向治疗副作用更严重","靶向治疗作用于特定分子或通路","靶向治疗不需要基因检测","靶向治疗仅用于晚期患者","分子靶向治疗与传统化疗的主要区别在于","v1",0,{"answer":33,"createTime":5,"id":34,"options":35,"question":40,"source":30,"type":31},[],238557795,[36,37,38,39],"高特异性","减少全身毒性","不需要分子检测","可能出现耐药性","下列哪项不是靶向治疗的共同特点",{"answer":42,"createTime":5,"id":43,"options":44,"question":49,"source":30,"type":31},[],238557796,[45,46,47,48],"HER2阳性","EGFR突变","ALK融合","BRAF突变","吉非替尼(Gefitinib)主要用于治疗哪种突变类型的肿瘤",{"answer":51,"createTime":5,"id":52,"options":53,"question":58,"source":30,"type":31},[],238557797,[54,55,56,57],"曲妥珠单抗","贝伐珠单抗","伊马替尼","利妥昔单抗","下列哪种药物属于抗血管生成类靶向药",{"answer":60,"createTime":5,"id":61,"options":62,"question":67,"source":30,"type":31},[],238557798,[63,64,65,66],"心脏毒性","皮疹和腹泻","出血倾向","神经系统毒性","下列哪种副作用与EGFR-TKIs类药物(如厄洛替尼)最相关",{"answer":69,"createTime":5,"id":70,"options":71,"question":75,"source":30,"type":31},[],238557799,[72,73,54,74],"拉帕替尼","西妥昔单抗","克唑替尼","下列哪种药物是抗HER2的单克隆抗体",{"answer":77,"createTime":5,"id":6,"options":78,"question":19,"source":30,"type":31},[],[8,9,10,11],{"answer":80,"createTime":5,"id":81,"options":82,"question":87,"source":30,"type":31},[],238557801,[83,84,85,86],"血常规","基因测序","心电图","超声检查","下列哪种检测方法常用于指导靶向治疗",{"answer":89,"createTime":5,"id":90,"options":91,"question":94,"source":30,"type":31},[],238557802,[55,92,56,93],"帕博昔利","纳武利尤单抗","下列哪种药物是小分子酪氨酸激酶抑制剂",{"answer":96,"createTime":5,"id":97,"options":98,"question":103,"source":30,"type":31},[],238557803,[99,100,101,102],"手足综合症","免疫相关性肺炎","骨髓抑制","肝功能异常","下列哪种不良反应属于免疫检查点抑制剂的典型副作用"]